REGINA — The 44th annual Terry Fox Run will take place in a month, on Sunday Sept. 15, in close to 600 communities across Canada, continuing Terry’s dream of a world without cancer by raising critical funds for life- changing cancer research.
Where does the money raised at a Terry Fox Run go? To research!
The Terry Fox Foundation has raised $900 million to fund life-changing research. Funded through the Terry Fox Research Institute (TFRI) and the recently launched Marathon of Hope Cancer Centres Network (MOHCCN), some very interesting and innovative research projects are happening in our own backyard.The MOHCCN is a powerful collective of the country’s top hospitals, research universities, and health authorities, including the University of Manitoba, Cancer Care Manitoba, Saskatchewan Cancer Agency, and the University of Saskatchewan.
Dr. Sachin Katyal is an Associate Professor at the University of Manitoba, Senior Scientist at the Paul Albrechtsen Research Institute, and Director of the Manitoba Tumour Bank at Cancer Care Manitoba. He is a leading researcher in precision oncology, a cancer treatment that targets the specific characteristics of each individual's tumour. Dr. Katyal is currently part of the Marathon of Hope Cancer Centres Network and co-leads a project with other cancer clinicians and researchers to pursue an end to cancer through precision medicine, which
targets the unique molecular characteristics of each cancer patient’s tumour.
Dr. Katyal is appreciative of the Terry Fox Run and the fundraisers that give so generously to it. “On the research side, we can see the light ahead, can see how much closer we are to huge breakthroughs in not only treating but preventing cancer. Each trial we take towards proving our theories takes time and money, test after test, searching and re-searching! When donors give to the Terry Fox Run, you enable us to get closer to that common dream of ending cancer.”
Join Dr. Katyal, his family, and colleagues at the Winnipeg Terry Fox Run or support him by donating online at run.terryfox.ca/Winnipeg.
Senior Research Scientists with the Saskatchewan Cancer Agency are Dr. Deborah Anderson and Dr. Franco Vizeacoumar. They were members of the Prairie Cancer Research Consortium, a pilot project of the MOHCCN.
Dr. Anderson is also the Director of Research with the Saskatchewan Cancer Agency and a Professor in Oncology as well as an Associate Member in Biochemistry, Microbiology and Immunology at the University of Saskatchewan. Her research lab is studying the role of the metastasis suppressor protein CREB3L1 in breast cancer progression with a goal to develop new drugs to block breast cancer metastasis.
Dr. Vizeacoumar is also a Senior Scientist at the Saskatchewan Cancer Agency and an Associate Professor in the Department of Oncology at the University of Saskatchewan. His research focuses on developing personalized targeted cancer therapies for solid tumors using a genetic approach known as synthetic lethality. This method involves identifying genetic alterations in cancer cells that can be exploited to create effective therapeutic targets, leading to more precise and personalized treatment options for cancer patients.You can support the Saskatchewan cancer research team at the Terry Fox Run by donating to run.terryfox.ca/Saskatoon.
In 1980 Terry said, “No matter what pain I suffer, it is nothing compared to the pain of those who have cancer...” Canadians are encouraged to register, fundraise, and participate in the Terry Fox Run to make an impact on cancer research, #NoMatterWhat.
